What target do you utilize in clinical practice for defining disease remission in RA?

Clinical trials have consistently shown that a treat-to-target strategy in RA achieves better outcomes than "usual care". In 2019, The American College of Rheumatology recommended four in particular: Rapid 3, DAS 28 ESR or CRP, CDAI or SDAI. Several years ago, our EMR IT team (EPIC) incorporated the...